Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer

Immune checkpoint inhibition (CPI) for metastatic colorectal cancer (mCRC) with deficient mismatch repair (dMMR) demonstrates high clinical activity that appears durable, but the impact of CPI on pathological tumor response is unknown. In this retrospective analysis, our objective was to assess path...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Natl Cancer Inst
Main Authors: Ludford, Kaysia, Cohen, Romain, Svrcek, Magali, Foo, Wai Chin, Colle, Raphael, Parc, Yann, Thomas, Jane Varkey, Morris, Van Karlyle, Kopetz, Scott, Chang, George J, Overman, Michael, Andre, Thierry
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Brief Communication
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7850519/
https://ncbi.nlm.nih.gov/pubmed/32294214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa052
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares